10Cheng JC,Chuang VP,Cheng SH, et al. Local radiotherapy with or without transcatheter arterial ehenoembolization for patients with unresectable hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys,2000,47 :435 - 442.
5Livraghi T, Makisalo H, Line PD. Treatment options in hepatoceUular carcinoma today [J]. Scand J Surg, 2011,100 (1):22-29.
6Giannelli G, Mazzocca A, FranSvea E, et al. Inhibiting TGF- beta signaling in hepatocellular carcinoma [J]. Biochim Biophys Acta, 2011,1815(2) :214-223.
7Moore-Smith L, Pasche B. TGFBR1 signaling and breast cancer [J]. J Mammary Gland Biol Neoplasia, 2011,16(2):89-95.
8Zhong Z, Carroll KD, Policarpio D, et al. Anti-transforming growth factor beta receptor II antibody has therapeutic efl'ieacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells [J]. Clin Cancer Res, 2010, 16(4) : 1191-1205.
9Ceballas MP, Parody JP, Alvarez ML, et al. Interferen-alpha2b and transforming growth factor-beta1 treatments on HCC cell lines: Are Wnt/beta-catenin pathway and Smads signaling connected in hepatocellular carcinoma [J]. Biochem Pharmacol, 2011,82 ( 11 ) : 1682-1691.
10Morris SM, Baek JY, Koszarek A, et al. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss [ J ]. Hepatology, 2012,55 ( 1 ) : 121-131.
